The investigation of anticancer drug-induced cardiomyopathy

The investigation of anticancer drug-induced cardiomyopathy - The investigation of anticancer drug-induced cardiomyopathy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000023209

Enrollment

1000

Registered

2016-08-16

Start date

2016-08-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug-induced cardiomyopathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Cancer patients scheduled for chemotherapy by using cardiotoxic drugs 2) Cancer patients with the history of using cardiotoxic drugs 3) Patients can provide informed consent

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
The evaluation of cardiac function by using echocardiography, cardiac MRI	—

Secondary

Measure	Time frame
The evaluation of the severity of double-strand breaks of DNA in mononuclear cells	—

Countries

Japan

Contacts

Public ContactMasayoshi Oikawa

Fukushima Medical University Department of Cardiovascular Medicine

moikawa@fmu.ac.jp024-547-1190

Outcome results